iiinova — where your digital self keeps evolving

Today we published a new report building on discussions with over 50 leaders from #healthcare, #research and industry at our recent Health Summit in Singapore. Learn more: bit.ly/4rELFdD

001

Oxford Nanopore @nanoporetech.com · 29/09/2026

We're proud to join @GeneticAlliance's global rare disease programme, RISE, helping expand access to genomic testing for families with unresolved genetic conditions and supporting evidence generation for nanopore sequencing. Learn more: bit.ly/4hsY6WR

020

Oxford Nanopore @nanoporetech.com · 28/09/2026

At #ASHG2026, Cora Vacher opens our Industry Education Session on Adaptive Sampling and multiomic insight, before Debarshi Mustafi shows how long reads resolve difficult variants in inherited retinal disease and retinoblastoma. bit.ly/4xMOo6B

000

Oxford Nanopore @nanoporetech.com · 26/09/2026

Everyone should have access to healthcare, even in remote regions. In the #nanoporeconf studio, Robert A. Edwards shared how portable nanopore sequencing has the potential to address gaps, making genomics more accessible to everyone.

020

Oxford Nanopore @nanoporetech.com · 25/09/2026

Rapid answers could make a real difference for people facing a brain tumour diagnosis. A new NHS pilot is expanding rapid genomic classification across England, with the ambition to build a joined-up approach & bring potential benefits to more patients. bit.ly/4jmZHOX

152

Oxford Nanopore @nanoporetech.com · 24/09/2026

On-the-spot pathogen identification. From initial characterisation of genomes to the rapid identification of variants, portable and accessible nanopore technology enables quick responses to public health emergencies globally. See what you're missing. bit.ly/4ArKtyk #WYMM

032

Oxford Nanopore @nanoporetech.com · 23/09/2026

In precision oncology, time matters. See how real-time genomic and methylation insights with nanopore sequencing has the potential to help classify cancer faster, enabling a future where rapid, informed treatment decisions could be a reality. Watch here: bit.ly/4cKa2k8

030

Oxford Nanopore @nanoporetech.com · 22/09/2026

On October 21, Pfizer will share how they replaced outsourced workflows across antibody discovery, plasmid verification, and cell-line characterisation, with Oxford Nanopore sequencing. Register here: bit.ly/4AlvF4t

001

Oxford Nanopore @nanoporetech.com · 21/09/2026

Take your research to the next level with gold-standard methylation sequencing. Oxford Nanopore delivers the highest-accuracy 5mC calling of all methods benchmarked. See the full dataset here: bit.ly/4xy1c0s

051

Oxford Nanopore @nanoporetech.com · 21/09/2026

This World Alzheimer’s Day, we’re highlighting researchers working to understand the biology behind this complex disease. Read how Kim Billingsley & her team are decoding the human brain to better understand the mechanisms behind neurodegeneration: bit.ly/4zLcq40

020

Oxford Nanopore @nanoporetech.com · 20/09/2026

86 malignancy types. Over 98% accuracy among classified research samples. A confident call within minutes of sequencing. New preprint demonstrates the potential of a nanopore-based methylation classifier for hematologic malignancy research. bit.ly/4cGDdEw

012

Oxford Nanopore @nanoporetech.com · 18/09/2026

"2 to 6 weeks" for molecular classification vs. hours with Oxford Nanopore sequencing. Min Sun Park (@UW) on why turnaround time isn't just a technical detail — it's a human one. RUO Learn more: bit.ly/4y1LX0V

010

Oxford Nanopore @nanoporetech.com · 17/09/2026

Developing cell and gene therapies is hard. Understanding the biology shouldn't be. By sequencing full-length DNA and RNA molecules directly, learn how Oxford Nanopore is helping researchers gain deeper insights, reduce risk, and accelerate development. bit.ly/4dzaxh6

021

Oxford Nanopore @nanoporetech.com · 16/09/2026

This month's Science Unlocked covers adaptation to genetic bottlenecks, cell-free DNA sequencing, and microbiome research. These studies showcase the advances in scientific research made possible by Oxford Nanopore technology. Read here: bit.ly/4rdi4Yx

000

Oxford Nanopore @nanoporetech.com · 15/09/2026

258 cancer genes. One assay. Real answers. Discover how Oxford Nanopore’s hereditary cancer panel reveals what others miss. Discover more: nanoporetech.com/hereditary-cancer-…

001

Oxford Nanopore @nanoporetech.com · 14/09/2026

New in Neuro-Oncology: researchers at Princess Máxima Center report on Sturgeon, their AI-based tool built on nanopore sequencing, used in their own paediatric neurosurgical workflow to help inform real-time surgical decisions. bit.ly/4y5v1pI RUO

000

Oxford Nanopore @nanoporetech.com · 11/09/2026

Not all biological answers lie in the DNA sequence. In this knowledge exchange, explore how gold-standard methylation sequencing with Oxford Nanopore reveals hidden insights that traditional methods miss — all from a single run. Register here: bit.ly/4xoxqed

001

Oxford Nanopore @nanoporetech.com · 10/09/2026

Have questions about EPI2ME? Now’s your chance to ask them! Head over to the Nanopore Community and add your questions for our EPI2ME experts to reply to them directly in the thread. Submit your questions now: bit.ly/4heKkqu

001

Oxford Nanopore @nanoporetech.com · 09/09/2026

Unbox the world’s smallest and most accessible sequencer. The MinION Mk1D is portable yet powerful, ideal for labs looking for rapid results without compromise. Simply plug it into your laptop and start sequencing, whether in the lab or in the field. bit.ly/4x6HfgR

051

Oxford Nanopore @nanoporetech.com · 09/09/2026

Does more mRNA in a tissue mean more protein made? Not necessarily. A new preprint from Monash University used nanopore sequencing to track LNP-delivered mRNA in mice and found a clear disconnect between mRNA delivery and protein expression across organs. bit.ly/4hTpcXH

010

Oxford Nanopore @nanoporetech.com · 09/09/2026

Last week, Sky News featured a programme, pioneered by Guy's and St Thomas' NHS Foundation Trust & being expanded through the NHS, which is exploring how rapid metagenomic sequencing can characterise unknown pathogens in clinical & public health settings. bit.ly/3VhUcHi

030

Oxford Nanopore @nanoporetech.com · 07/09/2026

Methylation is becoming a key biomarker in neurodegenerative disease. As Kim Billingsley put it, you need to see the variant and the epigenetics together on the same molecule, in the same run. With nanopore, you get that for free, without needing a separate assay. #Nanoporeconf

030

Oxford Nanopore @nanoporetech.com · 04/09/2026

Still relying on legacy approaches for microbial analysis? Join this webinar to discover the latest tools for resolving strain-level diversity, recovering complete genomes, and unlocking deeper insights from complex microbial communities. Register here: bit.ly/3UnBy0r

142

Oxford Nanopore @nanoporetech.com · 02/09/2026

Earlier cancer detection can change outcomes. Explore how Oxford Nanopore sequencing is helping researchers extract more information from a single liquid biopsy, opening new possibilities for non-invasive cancer monitoring. bit.ly/4iuxF3F

011

Oxford Nanopore @nanoporetech.com · 01/09/2026

New in Nature Communications: Amgen deCODE genetics sequenced 7,284 genomes on Oxford Nanopore, delivering gold-standard methylation calls. They found 702 CpG units where ageing impacts maternal & paternal alleles differently, beyond the reach of arrays. bit.ly/4qEn4W5

021

Oxford Nanopore @nanoporetech.com · 31/08/2026

6 studies show nanopore sequencing ID'ing bloodstream infections in <3.5 hrs, cutting AMR turnaround by up to 20 hrs, and catching culture-negative pathogens standard tests missed entirely. Real-time genomics is changing infectious disease response. bit.ly/3S8Fxxi

003

Oxford Nanopore @nanoporetech.com · 28/08/2026

Outbreak missed by routine surveillance. Caught by genomic surveillance. Max Bloomfield's research on infection control genomics is a great example of why real-time, precise data matters. bit.ly/3TrNq0K

000

Oxford Nanopore @nanoporetech.com · 27/08/2026

Chanatjit Cheawsamoot shared how nanopore sequencing delivers data the current standard of care misses and are now considering it earlier in the diagnostic pathway, rather than as a last‑resort test.

000

Oxford Nanopore @nanoporetech.com · 26/08/2026

100 million people in Africa live with rare diseases — most uncharacterised. At Stellenbosch University, nanopore sequencing has the potential to change that, delivering faster answers and bringing equitable access to genomic medicine closer to reality.

020

Oxford Nanopore @nanoporetech.com · 25/08/2026

Oxford Nanopore today announces the appointment of David Miller as Chief Development and Product Officer (CDPO) and Conor McKechnie as Chief Marketing and Communications Officer (CMCO), joining on 1st September and 1st October respectively. bit.ly/3UkiUqb

000

Oxford Nanopore @nanoporetech.com · 24/08/2026

In this webinar, Marilyn Li shares data from her team’s work at Children’s Hospital of Philadelphia applying real-time Oxford Nanopore sequencing to classify acute leukaemia and tumours in minutes. Learn more: bit.ly/3OtB4mY For research use only.

000

Oxford Nanopore @nanoporetech.com · 21/08/2026

Faster infection detection. Richer microbial insights. Dive into some of the standout metagenomics talks from London Calling 2026 and discover the workflows, protocols, and masterclasses to help you get started with Oxford Nanopore metagenomic sequencing. bit.ly/4wEYXZp

011

Oxford Nanopore @nanoporetech.com · 20/08/2026

"This approach can facilitate access to precision therapies" — detecting alterations standard NGS finds tricky to capture. Dr. Vincent Philippe Lavallee on Oxford Nanopore sequencing research in paediatric oncology. RUO (research use only) bit.ly/4w1x3Xi

011

Oxford Nanopore @nanoporetech.com · 19/08/2026

Today we announce our results for H1 2026. Revenue increased to £116.7 million, up 12.3% at constant currency, while gross margin improved by 400bps to 62.2%. Read the full H1 2026 results: bit.ly/3SCOOh8

061

Oxford Nanopore @nanoporetech.com · 18/08/2026

Running samples one by one limits how far your study can go. The cDNA Barcoding Kit lets you run more RNA samples together, making it easier to move beyond small pilots and generate datasets big enough to actually answer your research question. bit.ly/4aECDGi

100

Oxford Nanopore @nanoporetech.com · 17/08/2026

What if the clues to neurodegenerative disease have been hiding in plain sight? Kimberley Billingsley & the NIH team discovered thousands of transcripts missed by short-read sequencing, unlocking a deeper view of Alzheimer’s & Parkinson’s mechanisms. bit.ly/4q0mCAX

021

Oxford Nanopore @nanoporetech.com · 13/08/2026

New study from Jessa Hospital reports the first published in-house clinical validation of SQK-MAB114.24. Researchers achieved same-day 16S results in <7h & detected additional clinically relevant pathogens in culture-negative & polymicrobial infections. bit.ly/4wUNqFJ

000

Oxford Nanopore @nanoporetech.com · 11/08/2026

If you’re a researcher, you’ll know that benchmarking data is an important tool. In this Q&A with our Director of Applications Bioinformatics, discover what benchmarking really means, why it matters, and how to make the most of benchmarking data. bit.ly/44nUIoP

000

Oxford Nanopore @nanoporetech.com · 10/08/2026

For rare disease, every dataset represents a family waiting for answers. Discover how advanced tertiary analysis can transform Oxford Nanopore sequencing data into critical insights, pushing rare disease research forward. Join the webinar. bit.ly/3RH3U4A

000

Oxford Nanopore @nanoporetech.com · 06/08/2026

A missed signal—hiding in plain sight. At London Calling 2026, Alvin Ng described how methylation data, initially overlooked, revealed a clear pattern linked to HRD and how nanopore sequencing can unlock these additional layers from the same dataset.

001

Oxford Nanopore @nanoporetech.com · 06/08/2026

We're hosting another Ask Me Anything session on the Community with our EMEAI MinION specialists. Bring your questions about MinION and get answers directly from the team. bit.ly/4xmFyfV

000

Oxford Nanopore @nanoporetech.com · 04/08/2026

RNA sequencing has often meant working from fragments. The PCR‑cDNA workflow enables full-length transcript sequencing, shifting from reconstruction to observation of RNA structure. bit.ly/4xfiwZ2

000

Oxford Nanopore @nanoporetech.com · 01/08/2026

Revealing resistance, tracking outbreaks, and monitoring vaccine coverage in days instead of weeks. At #ESCMID, Jose Alexander shared how rapid microbial sequencing is supporting faster decisions for more effective infection control. bit.ly/4vW2WAi

000

Oxford Nanopore @nanoporetech.com · 29/07/2026

At #NanoporeConf, Rowan shared the potential of Oxford Nanopore WGS for faster, more accurate cancer characterisation — including the possibility of detecting critical mutations missed by other methods & streamlining cancer identification. bit.ly/4aSqkX3

020

Oxford Nanopore @nanoporetech.com · 28/07/2026

New FDA draft guidance states: short reads are no longer enough to ensure safe cell & gene QC. This blog explores how a single long Oxford Nanopore read QC test could provide more comprehensive insights to accelerate the development of safer therapies. bit.ly/4wsREDW

021

Oxford Nanopore @nanoporetech.com · 27/07/2026

Portable yet powerful, MinION is ideal for labs looking for rapid results without compromise. Join our latest knowledge exchange to learn how real-time, portable sequencing can provide you with rapid results without compromise. Register here: bit.ly/4wl6Umy

020

Oxford Nanopore @nanoporetech.com · 24/07/2026

Fragmented assays can create friction between R&D, development and QC. As cell and gene therapies move towards commercialisation, could a single platform bring multiple analytical assessments together within a single workflow? Learn more: bit.ly/3T4xnpB

010

Oxford Nanopore @nanoporetech.com · 23/07/2026

Direct RNA offers a unique view of native RNA, but scaling experiments hasn’t been easy. Our new Direct RNA Barcoding Kit enables multiplexing, so you can run more samples and uncover RNA biology that single-sample studies miss. bit.ly/4aNcWn6

030

Oxford Nanopore @nanoporetech.com · 22/07/2026

For 10+ years, short reads left the ocean's most dominant microbes unstudied. Now we can finally see them. Steven & the team used nanopore reads to assemble the ocean's most abundant "Ghost Taxa." The microbes, invisible for a decade, could also reflect the condition of the reef around them. #WYMM

032

Oxford Nanopore @nanoporetech.com · 22/07/2026

Dr. Ahmad Abou Tayoun is leading efforts to streamline genomics research in the Middle East. Using Oxford Nanopore sequencing, his team studies multiple layers of complexity in one comprehensive approach, helping researchers reduce time and focus on discovery.

020